Purpose: To investigate the use of the Lucy ® Stereotactic Phantom (Standard Imaging, Inc.) for Gamma Knife Perfexion radiosurgery quality assurance of the imaging, treatment planning, and dose delivery processes. End-to-end testing of the Perfexion and Gamma Plan version 10.1 has not been previously examined in literature.

Methods: The phantom was imaged using both the CT and T1- and T2-weighted MR sequences used for treatment planning. For imaging, the isocentric volume insert and fiducial markers were positioned within the phantom. Scans were transferred to the Gamma Plan treatment planning system and were evaluated for geometric and fusion accuracy. A plan was created to deliver 12Gy to the 50% isodose line to the 5.25cm volume. During dose delivery, Gafchromic EBT2 film was positioned in the film insert to replicate the position of the target volume. Dose results were analyzed using RIT software (Radiologic Imaging Technology, Inc.).

Results: Image fusion integrity was inspected by overlaying the MR and CT markers (5 fiducial markers spaced 5mm apart) and visually examining the resulting volume insert overlap between the three scans. Geometric accuracy was evaluated by contouring three volumes using Gamma Plan contouring tools. Agreement within 1.1%, 6.7% and 12.2% of the actual volumes was seen with the T1-weighted, T2-weighted, and CT images, respectively. The volume-based acquisition and 1mm slice thickness of the T1-weighted sequence resulted in the most accurate measurement. Geometric measurements along two dimensions showed acceptable accuracy for all imaging modalities within 1.6%. Dosimetry results agreed well with the planned dose. The EBT2 film was calibrated for absolute dose measurements using a dose calibration curve for 0.1-30 Gy and the calibration curve was verified to have <3% error above 1Gy.

Conclusions: The Lucy phantom allows for comprehensive quality assurance testing of the Gamma Knife Perfexion radiosurgery process.

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4735034DOI Listing

Publication Analysis

Top Keywords

treatment planning
12
gamma plan
12
gamma knife
8
knife perfexion
8
end-to-end testing
8
stereotactic phantom
8
dose delivery
8
volume insert
8
fiducial markers
8
volume dose
8

Similar Publications

Background: Acceptability of malaria chemoprevention interventions by caregivers is crucial for overall programme success. This study assessed coverage and acceptability of Seasonal Malaria Chemoprevention (SMC) in selected communities in the Northern part of Ghana.

Methods: An analytical cross-sectional design was conducted from "July 23rd to August 4th, 2020-a 12-day period that covered 5 days of the first SMC implementation cycle and 7 days post-implementation.

View Article and Find Full Text PDF

Background: Recently, there has been an increase in the prevalence of childhood obesity in Malaysia, raising concerns about increased cardiometabolic morbidity. MyBFF@school is a multifaceted program comprising physical activity, nutritional education, and psychological empowerment introduced to combat childhood obesity in Malaysia. The efficacy of a six-month intervention on the body composition of overweight and obese primary schoolchildren was evaluated.

View Article and Find Full Text PDF

Background: People with intellectual disabilities are less likely to have access to palliative care, and the evidence shows that their deaths are often unanticipated, unplanned for, and poorly managed. Within the general population, people from minoritised ethnic groups are under-represented within palliative care services. End-of-life care planning with people with intellectual disabilities from minoritised ethnic groups may be a way to address these issues.

View Article and Find Full Text PDF

Breast cancer survivors face employment challenges. How to promote BC's return to work is important for improving their quality of life and promoting recovery. Numerous studies have reported that BC survivors encounter employment challenges due to cognitive limitations, alongside factors.

View Article and Find Full Text PDF

Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review.

Blood Rev

January 2025

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China; Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address:

Cancer therapy-induced thrombocytopenia (CT-IT) is one of the most common hematological toxicities of anti-cancer therapy, often leading to treatment dose reduced, postponed, or treatment plans altered or even discontinued. Thrombopoietin (TPO) is the only key regulatory factor in platelet production, and TPO receptor is considered an ideal target for the treatment of thrombocytopenia. Thrombopoietic agents, including recombinant human thrombopoietin (rhTPO) and thrombopoietin receptor agonists (TPO-RAs), bind to different regions of the TPO receptor, activating downstream signaling pathways to increase platelet levels.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!